Literature DB >> 17009010

The role of protein kinase CK2 in intestinal epithelial cell inflammatory signaling.

Kuljit Parhar1, Jennifer Morse, Baljinder Salh.   

Abstract

BACKGROUND: The transcription factor NF-kappaB is believed to play a key pathophysiological role in chronic intestinal inflammation. Further characterization of its mechanism of regulation, predominantly through cell signaling pathways, may provide clues as to the means of its intervention. One such potential signaling candidate is the protein kinase CK2. Despite its known ability to influence NF-kappaB activation, it has received no attention in this particular setting. AIM: To characterize the aspects of its activation in response to IL-1beta in the colonic cell lines Caco2 and HCT116.
MATERIALS AND METHODS: A biochemical analysis of kinase activation was performed using phospho-specific antibodies as well as immune complex kinase assays; transcription factor activity was measured by transient transfection and luciferase-based NF-kappaB reporter assays; pro-inflammatory molecule expression was determined using RT-PCR.
RESULTS: In this report, we show an enhanced activation of CK2 bound to IKKgamma or the p65 subunit of the NF-kappaB in response to IL-1beta stimulation of intestinal epithelial cells. Using two established NF-kappaB reporters, we demonstrate that CK2 is involved in NF-kappaB regulation through the p65 serine 529 site. Using co-immunoprecipitation studies, we also show that p65 is bound to CK2 predominantly in the nucleus. From a functional perspective, two CK2 specific inhibitors were then shown to attenuate IL-8 reporter activation. Finally, the expression of a series of pro-inflammatory molecules including IL-8, GRO-alpha, MCP-1, TNFalpha and iNOS were variably affected in response to CK2 inhibition.
CONCLUSION: CK2 plays an active role in NF-kappaB signaling in intestinal epithelial cell lines and may represent a possible target for intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17009010     DOI: 10.1007/s00384-006-0193-7

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  37 in total

1.  Expression and release of IL-18 binding protein in response to IFN-gamma.

Authors:  J Paulukat; M Bosmann; M Nold; S Garkisch; H Kämpfer; S Frank; J Raedle; S Zeuzem; J Pfeilschifter; H Mühl
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

2.  Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.

Authors:  R Romieu-Mourez; E Landesman-Bollag; D C Seldin; A M Traish; F Mercurio; G E Sonenshein
Journal:  Cancer Res       Date:  2001-05-01       Impact factor: 12.701

3.  Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase.

Authors:  M Sayed; S O Kim; B S Salh; O G Issinger; S L Pelech
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

4.  Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine.

Authors:  T T MacDonald; P Hutchings; M Y Choy; S Murch; A Cooke
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

5.  Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation.

Authors:  J A McElhinny; S A Trushin; G D Bren; N Chester; C V Paya
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

6.  Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit.

Authors:  T A Bird; K Schooley; S K Dower; H Hagen; G D Virca
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

7.  Interferon-gamma stimulates the expression of the inducible cAMP early repressor in macrophages through the activation of casein kinase 2. A potentially novel pathway for interferon-gamma-mediated inhibition of gene transcription.

Authors:  James R Mead; Timothy R Hughes; Scott A Irvine; Nishi N Singh; Dipak P Ramji
Journal:  J Biol Chem       Date:  2003-02-27       Impact factor: 5.157

8.  Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.

Authors:  D Wang; A S Baldwin
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

9.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

10.  A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation.

Authors:  M T Diaz-Meco; E Berra; M M Municio; L Sanz; J Lozano; I Dominguez; V Diaz-Golpe; M T Lain de Lera; J Alcamí; C V Payá; F Arenzana-Seisedos; J L Virelizier; J Moscat
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

View more
  12 in total

Review 1.  Protein kinase CK2, an important regulator of the inflammatory response?

Authors:  Nishi N Singh; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

2.  IL-1 receptor regulates S100A8/A9-dependent keratinocyte resistance to bacterial invasion.

Authors:  B S Sorenson; A Khammanivong; B D Guenther; K F Ross; M C Herzberg
Journal:  Mucosal Immunol       Date:  2011-10-26       Impact factor: 7.313

3.  Transient changes in the localization and activity of ecto-nucleotidases in rat hippocampus following lipopolysaccharide treatment.

Authors:  Agnes Kittel; Beata Sperlágh; Julie Pelletier; Jean Sévigny; Terence L Kirley
Journal:  Int J Dev Neurosci       Date:  2007-05-17       Impact factor: 2.457

4.  The role of protein kinase CK2 in glioblastoma development.

Authors:  Haitao Ji; Zhimin Lu
Journal:  Clin Cancer Res       Date:  2013-10-28       Impact factor: 12.531

Review 5.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

6.  Protein kinase CK2 is a critical regulator of epithelial homeostasis in chronic intestinal inflammation.

Authors:  S Koch; C T Capaldo; R S Hilgarth; B Fournier; C A Parkos; A Nusrat
Journal:  Mucosal Immunol       Date:  2012-07-04       Impact factor: 7.313

7.  Requirement for nuclear factor kappa B signalling in the interleukin-1-induced expression of the CCAAT/enhancer binding protein-delta gene in hepatocytes.

Authors:  Saira Ali; Nishi N Singh; Hatice Yildirim; Dipak P Ramji
Journal:  Int J Biochem Cell Biol       Date:  2009-09-30       Impact factor: 5.085

8.  The interferon-gamma-mediated inhibition of lipoprotein lipase gene transcription in macrophages involves casein kinase 2- and phosphoinositide-3-kinase-mediated regulation of transcription factors Sp1 and Sp3.

Authors:  Sandra M Harris; Elizabeth J Harvey; Timothy R Hughes; Dipak P Ramji
Journal:  Cell Signal       Date:  2008-08-28       Impact factor: 4.315

9.  A critical role for CK2 in cytokine-induced activation of NFκB in pancreatic β cell death.

Authors:  Caroline Jaksch; Peter Thams
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

10.  Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer's disease pathology.

Authors:  Andrea F N Rosenberger; Tjado H J Morrema; Wouter H Gerritsen; Elise S van Haastert; Hripsime Snkhchyan; Riet Hilhorst; Annemieke J M Rozemuller; Philip Scheltens; Saskia M van der Vies; Jeroen J M Hoozemans
Journal:  J Neuroinflammation       Date:  2016-01-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.